⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GLUE News
Monte Rosa Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
GLUE
Monte Rosa Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates
globenewswire.com
GLUE
Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
GLUE
Form 8-K
sec.gov
GLUE
Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
GLUE
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
globenewswire.com
GLUE
Form 8-K
sec.gov
GLUE
Monte Rosa Therapeutics Announces First Quarter 2026 Financial Results and Business Updates
globenewswire.com
GLUE
Gluware Unveils Industry-First Agentic Feature-Aware Vulnerability Detection and Network Remediation
prnewswire.com
GLUE
Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
GLUE